Get notified of page updates
Education > XRAY > Ovarian Cancer

FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program

How To Use XRAY
Search by Topic Submit an Article for Review

Ovarian Cancer

1 through 10 of 79

Relevance: Medium-High

Strength of Science: Medium-High

View Related Clinical Trials

Study : Use of cannabis for cancer symptom management

Relevance: Medium-High

Strength of Science: Medium-High

View Related Clinical Trials

Most relevant for: People with cancer interested in using cannabis to help manage symptoms.

Among people with cancer, interest in the use of cannabis to manage cancer symptoms and treatment side effects is high. The world's leading professional organization of oncologists has published strategies to help adults with cancer and their healthcare providers have open, nonjudgmental discussions about the use of cannabis to manage cancer symptoms. (Posted 9/27/24)

Read More

Relevance: High

Research Timeline: Post Approval

View Related Clinical Trials

Topic : Acupressure for cancer symptom relief

Relevance: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: People diagnosed with cancer

Acupressure is a safe treatment that can be used to relieve some symptoms of cancer and side effects of treatment. Light pressure applied to key points on the body may help with fatigue, sleep, nausea and possibly other symptoms as well. (Posted 8/1/24)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

Strength of Science: High

Research Timeline: Post Approval

Topic : The drug Enhertu is FDA-approved for any advanced or metastatic HER2-positive tumors

Relevance: Medium-High

Strength of Science: High

Research Timeline: Post Approval

Most relevant for: People with advanced HER2-positive cancer

The FDA granted accelerated approval of Enhertu for people with any HER2-positive tumor that is metastatic or cannot be surgically removed. Eligible patients must have had previous treatment such as chemotherapy or hormone therapy. (Posted 7/19/24)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

View Related Clinical Trials

Topic : Experts call for early palliative care for cancer patients

Relevance: Medium-High

View Related Clinical Trials

Most relevant for: Cancer patients

People with cancer need support and care not only at the end of life but from the time of diagnosis. At the 2024 American Society of Clinical Oncology (ASCO) annual meeting, the organization’s president urged cancer healthcare professionals to make palliative care central to cancer treatment. (Posted 7/17/24)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

View Related Clinical Trials

Update : News from the FDA: New ovarian cancer treatment and imaging drug

Relevance: Medium-High

View Related Clinical Trials

Most relevant for: People with ovarian cancer.

The FDA recently approved a new treatment for some people with ovarian cancer.  The FDA also approved a new imaging drug that can help surgeons find and remove ovarian cancer. (Posted 5/30/24)

Este artículo está disponible en español.

Read More

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Study : Ovary removal reduces risk of death from any cause in people with BRCA mutations

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: People who have had a risk reducing bilateral oophorectomy

People who test positive for an inherited BRCA1 or BRCA2 mutation can reduce their risk of ovarian cancer by having both ovaries and fallopian tubes removed. A study published in 2024 found an added benefit of this surgery – a lower risk of death from any cause by age 75. (Posted 5/23/24)

Este artículo está disponible en español.

Read More

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Study : Genetic testing among people with cancer can find mutations that may affect treatment and prevention

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: People diagnosed with cancer who have not yet had genetic testing

Despite national guidelines recommending genetic testing, less than 10 percent of eligible patients had genetic testing within two years after their cancer diagnosis. Among those who had testing, 10-30 percent had an inherited mutation that could affect their medical care. (Posted 3/15/2024)

Este artículo está disponible en español.

Read More

Relevance: High

Quality of Writing: Medium-High

Article : Genetic testing and the future of medicine

Relevance: High

Quality of Writing: Medium-High

Most relevant for: People interested in genetic testing.

An article published in Katie Couric Media discusses genetic testing and how it can impact health. The author talked with Dr. Robert Steiner, a doctor who specializes in genetics. He talked about genetic testing and how the results can affect health and change lives. (Posted 9/28/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-Low

Quality of Writing: Medium

Research Timeline: Animal Studies

View Related Clinical Trials

Article : Promising drug for cancer treatment begins clinical trials

Relevance: Medium-Low

Quality of Writing: Medium

Research Timeline: Animal Studies

View Related Clinical Trials

Most relevant for: People with solid tumors.

Researchers at City of Hope are testing a new type of cancer treatment drug. When tested in animals and cells taken from human cancers, this new drug prevented the growth of many types of cancer. Initial clinical trials in people have just started. (Posted 9/7/23)

Este artículo está disponible en español.

Read More

Relevance: Medium-High

View Related Clinical Trials

Topic : Reducing ovarian cancer risk without removing the ovaries

Relevance: Medium-High

View Related Clinical Trials

Most relevant for: People who are not at high risk of ovarian cancer who are having pelvic surgery

A leading ovarian cancer organization has recommended that all women who have pelvic surgery should also consider removing their fallopian tubes to reduce their risk of ovarian cancer. (Posted 7/18/23)

Read More

This Portal Sponsored By:

AstraZeneca